Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Fierce Biotech
Monday, March 17, 2014 - 10:51am
tags:
MK-3475, Merck, Five Prime, cancer immunotherapy, Bristol-Myers Squibb
Bristol-Myers' Eliquis gets new FDA nod for use after ortho surgery
Fierce Pharma
Monday, March 17, 2014 - 10:49am
tags:
Eliquis, FDA, Bristol-Myers Squibb, Pfizer, knee replacement, hip replacements
Sovaldi's Terrific Launch
Seeking Alpha
Monday, March 17, 2014 - 10:35am
tags:
drug launches, Sovaldi, hepatitis C, Gilead Sciences
Intuitive Surgical da Vinci hysterectomy procedures to accelerate, says Wedbush
Yahoo/Fly on the Wall
Monday, March 17, 2014 - 10:33am
tags:
Da Vinci Surgical System, devices, hysterectomies, Intuitive Surgical
Arena Down With Overall Market - Sales Data No Help
Seeking Alpha
Monday, March 17, 2014 - 10:32am
tags:
Arena Pharmaceuticals, Eisai, Belviq
Amgen drug meets goal for those with high genetic cholesterol
Yahoo/Reuters
Monday, March 17, 2014 - 10:25am
tags:
Amgen, cholesterol, evolocumab
The best-selling cancer drugs in 2013 and 2018: Roche dominates while immunotherapies, Johnson & Johnson emerge as contenders
First Word Pharma
Monday, March 17, 2014 - 10:06am
tags:
Roche, cancer, JNJ
FDA Concerns Are the Least of These Drugs' Worries
Motley Fool
Monday, March 17, 2014 - 9:53am
tags:
FDA, PCSK9 inhibitors, Regeneron, Sanofi, Merck, alirocumab
Pfizer's Pipeline Remains Healthy, Stock Heading To $40
Seeking Alpha
Monday, March 17, 2014 - 8:40am
tags:
Pfizer, Zoetis, Celebrex
Viagra scientist chases new sexual health breakthrough
Financial Times
Monday, March 17, 2014 - 8:39am
tags:
Viagra, Plethora Solutions, premature ejaculation, PSD502, Priligy, Furiex Pharmaceuticals, Tempe
Glaxo to Bring Doctors In-House as Educational Speakers
Bloomberg
Monday, March 17, 2014 - 8:36am
tags:
GSK, physicians
Coffee Fuels Drive for Drugs for Parkinson’s to Dementia
Bloomberg
Monday, March 17, 2014 - 8:34am
tags:
caffeine, Parkinson's Disease, Merck, Kyowa Hakko Kirin, Nouriast
Novartis gave doctors thousands to prescribe pills, feds allege
Newsday, NY
Sunday, March 16, 2014 - 11:55am
tags:
Novartis, legal
Intercept Announces Positive Pivotal Phase 3 POISE Trial Results
Yahoo/Globe Newswire
Sunday, March 16, 2014 - 11:46am
tags:
Intercept Pharma, obeticholic acid, primary biliary cirrhosis
Investors Don't Celebrate Celebrex Decision Favoring Cheap Generics
Motley Fool
Sunday, March 16, 2014 - 11:45am
tags:
Pfizer, Celebrex, patents, generics
Is Pfizer a Buy?
Wall St Cheat Sheet
Sunday, March 16, 2014 - 11:43am
tags:
Pfizer
Will Obamacare Harm These Biotech Stocks?
Motley Fool
Saturday, March 15, 2014 - 12:52pm
tags:
Celgene
Orchid Pharma gets nod for CDR
Business Standard, India
Saturday, March 15, 2014 - 10:39am
tags:
Orchid Pharma
Exuberant, Yes: Michael King on How the Oncology Drug Development Machine Builds Biotech Wealth
Jutia Group
Saturday, March 15, 2014 - 10:37am
tags:
Can AbbVie Continue Its Bull Run?
Motley Fool
Saturday, March 15, 2014 - 10:13am
tags:
AbbVie

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.